Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease

Liv Tybjærg Nordestgaard1, Mette Christoffersen1, Ruth Frikke-Schmidt1,2

  • 1Department of Clinical Biochemistry, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.

Insights

Preventing dementia is possible by addressing cardiovascular risk factors like high BMI and smoking, potentially reducing 40% of cases. This review examines links between cardiovascular disease risks and Alzheimer's disease and non-Alzheimer dementia.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Alzheimer's disease and vascular dementia are leading causes of cognitive decline.
  • Cardiovascular disease risk factors are increasingly linked to dementia development.
  • A significant portion of dementia cases may be preventable through lifestyle modifications.

Purpose of the Study:

  • To review the association between atherosclerotic cardiovascular disease risk factors and dementia risk.
  • To explore shared pathogenic mechanisms between dementia and cardiovascular disease.
  • To differentiate the impact of risk factors in midlife versus late life.

Main Methods:

  • Systematic review of current evidence.
  • Analysis of risk factors including BMI, lipids, hypertension, diabetes, NAFLD, physical activity, smoking, diet, gut microbiome, and genetics.
  • Comparison of risk factor associations at different life stages.

Main Results:

  • Modifiable cardiovascular risk factors are strongly associated with increased risk of both Alzheimer's disease and non-Alzheimer dementia.
  • Shared pathways likely exist between cardiovascular disease and dementia pathogenesis.
  • The timing of exposure to risk factors (midlife vs. late life) may influence dementia risk.

Conclusions:

  • Targeting cardiovascular risk factors offers a promising strategy for dementia prevention.
  • Lifestyle interventions focusing on cardiovascular health can reduce dementia incidence.
  • Further research into shared mechanisms and life-stage-specific risks is warranted.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
159
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
45
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
25
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
66
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
32